MAGNESIUM

MAGNESIUM was reported 441658 times

MAGNESIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 119 0.5197
1 VAGINAL FLATULENCE 103 0.3399
2 SWOLLEN JOINT COUNT 73 0.2920
3 LUPUS VULGARIS 359 0.2849
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 551 0.2751
5 C-REACTIVE PROTEIN 254 0.2740
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 132 0.1976
7 SWOLLEN JOINT COUNT INCREASED 606 0.1898
8 RHEUMATIC FEVER 777 0.1741
9 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 354 0.1707
10 X-RAY ABNORMAL 304 0.1698
11 FACET JOINT SYNDROME 490 0.1504
12 DISLOCATION OF VERTEBRA 339 0.1485
13 PERIPHERAL VENOUS DISEASE 565 0.1382
14 PORPHYRIA ACUTE 171 0.1192
15 RETINITIS 206 0.1191
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 847 0.1181
17 DUODENAL ULCER PERFORATION 872 0.1171
18 RHEUMATOID FACTOR POSITIVE 649 0.1122
19 C-REACTIVE PROTEIN ABNORMAL 636 0.0990
20 MUSCLE INJURY 776 0.0936
21 BREAST CANCER STAGE III 517 0.0797
22 FOLLICULITIS 837 0.0797
23 HELICOBACTER INFECTION 814 0.0791
24 PEMPHIGUS 983 0.0785
25 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 497 0.0764
26 BONE EROSION 247 0.0698
27 LIP DRY 626 0.0689
28 DRUG TOLERANCE DECREASED 192 0.0683
29 INFUSION SITE REACTION 202 0.0676
30 FEMALE GENITAL TRACT FISTULA 113 0.0661
31 BLEPHAROSPASM 404 0.0641
32 BLOOD MAGNESIUM DECREASED 549 0.0635
33 AUTOIMMUNE DISORDER 603 0.0618
34 HAND DEFORMITY 809 0.0616
35 SERONEGATIVE ARTHRITIS 70 0.0611
36 LIVE BIRTH 502 0.0599
37 BURSITIS 727 0.0599
38 WOUND INFECTION 655 0.0598
39 PERICARDITIS 975 0.0580
40 ONYCHOMADESIS 234 0.0557
41 JOINT RANGE OF MOTION DECREASED 723 0.0539
42 SYNOVITIS 972 0.0539
43 GRIP STRENGTH DECREASED 449 0.0510
44 SCIATICA 810 0.0508
45 RADICULOPATHY 133 0.0504
46 APLASTIC ANAEMIA 262 0.0501
47 INFUSION SITE DISCHARGE 84 0.0479
48 HYPERCHOLESTEROLAEMIA 435 0.0450
49 ULCER HAEMORRHAGE 302 0.0446
50 RECALLED PRODUCT 77 0.0445
51 GLOSSODYNIA 992 0.0443
52 IRRITABLE BOWEL SYNDROME 939 0.0437
53 FIBROMYALGIA 1063 0.0437
54 SYSTEMIC INFECTION 70 0.0422
55 BLOOD PRESSURE SYSTOLIC ABNORMAL 104 0.0420
56 WALKING AID USER 273 0.0414
57 CHRONIC SINUSITIS 151 0.0402
58 EYE INJURY 122 0.0401
59 EXOSTOSIS 353 0.0386
60 PROCTITIS 108 0.0385
61 LIVER INJURY 945 0.0385
62 BLOOD PRESSURE DIASTOLIC ABNORMAL 96 0.0377
63 WOUND 1039 0.0371
64 NAIL DISORDER 321 0.0367
65 EYELID PAIN 74 0.0364
66 OBESITY 577 0.0362
67 MATERNAL EXPOSURE TIMING UNSPECIFIED 134 0.0356
68 INFUSION SITE BRUISING 73 0.0338
69 LOWER LIMB FRACTURE 648 0.0337
70 ELECTRIC SHOCK SENSATION 88 0.0314
71 TASTE DISORDER 637 0.0314
72 PSORIATIC ARTHROPATHY 1253 0.0308
73 CARBOHYDRATE ANTIGEN 125 INCREASED 105 0.0308
74 TYPE 2 DIABETES MELLITUS 1032 0.0306
75 INFUSION SITE HAEMORRHAGE 100 0.0304
76 NIGHT SWEATS 964 0.0299
77 INFUSION SITE PRURITUS 94 0.0298
78 IMPAIRED HEALING 970 0.0295
79 SEASONAL ALLERGY 414 0.0292
80 TENDON PAIN 221 0.0292
81 PULMONARY FIBROSIS 559 0.0291
82 SYSTEMIC LUPUS ERYTHEMATOSUS 1032 0.0290
83 GAIT INABILITY 951 0.0284
84 CONTRAINDICATED PRODUCT ADMINISTERED 848 0.0280
85 OSTEOARTHRITIS 1161 0.0274
86 INFUSION SITE SWELLING 171 0.0271
87 FOOT DEFORMITY 296 0.0267
88 BACK INJURY 290 0.0266
89 DEVICE INFUSION ISSUE 66 0.0266
90 PRESCRIBED OVERDOSE 515 0.0266
91 BLOOD CHOLESTEROL INCREASED 1225 0.0263
92 BLOOD PRESSURE SYSTOLIC DECREASED 119 0.0261
93 WEIGHT FLUCTUATION 266 0.0254
94 STOMA SITE DISCHARGE 67 0.0245
95 SPONDYLITIS 88 0.0242
96 MULTIPLE ALLERGIES 189 0.0241
97 INFUSION SITE PAIN 308 0.0239
98 HIP ARTHROPLASTY 363 0.0237
99 ARTHROPATHY 1313 0.0236
100 INFUSION SITE ERYTHEMA 198 0.0235
101 FINGER DEFORMITY 113 0.0233
102 LUPUS-LIKE SYNDROME 208 0.0229
103 HYPOMAGNESAEMIA 315 0.0226
104 MUSCULOSKELETAL PAIN 1184 0.0226
105 RED BLOOD CELL SEDIMENTATION RATE INCREASED 250 0.0226
106 TUMOUR MARKER INCREASED 108 0.0225
107 STOMATITIS 1363 0.0225
108 JOINT DISLOCATION 233 0.0220
109 OEDEMA 1192 0.0220
110 NORMAL NEWBORN 119 0.0219
111 EAR PAIN 425 0.0218
112 BLISTER 1224 0.0218
113 SPINAL STENOSIS 89 0.0215
114 INFUSION RELATED REACTION 1419 0.0214
115 BLOOD IRON DECREASED 251 0.0211
116 LOWER RESPIRATORY TRACT INFECTION 958 0.0210
117 BREAST CANCER STAGE II 173 0.0208
118 ONYCHOMYCOSIS 91 0.0207
119 HYPERACUSIS 77 0.0207
120 MOBILITY DECREASED 1480 0.0206
121 FAECES HARD 80 0.0205
122 THERAPEUTIC PRODUCT EFFECT DECREASED 919 0.0205
123 WHEEZING 1214 0.0205
124 SKIN ABRASION 96 0.0203
125 BRAIN FOG 318 0.0203
126 SLEEP DISORDER 1417 0.0201
127 HEPATIC CIRRHOSIS 377 0.0200
128 MENISCUS INJURY 123 0.0200
129 PARANASAL SINUS DISCOMFORT 75 0.0198
130 LUNG DISORDER 959 0.0195
131 KNEE ARTHROPLASTY 411 0.0195
132 PRESCRIBED UNDERDOSE 389 0.0195
133 DRY MOUTH 1570 0.0193
134 RED CELL DISTRIBUTION WIDTH INCREASED 80 0.0192
135 BLOOD PRESSURE DIASTOLIC DECREASED 141 0.0191
136 SINUSITIS 1957 0.0191
137 PLANTAR FASCIITIS 64 0.0191
138 DISCOMFORT 1158 0.0190
139 TENDON DISORDER 123 0.0188
140 BLOOD PRESSURE DIASTOLIC INCREASED 87 0.0188
141 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 320 0.0188
142 MIGRAINE 1783 0.0187
143 HEPATIC ENZYME INCREASED 1251 0.0183
144 ON AND OFF PHENOMENON 101 0.0182
145 EAR INFECTION 483 0.0181
146 FREQUENT BOWEL MOVEMENTS 490 0.0181
147 COMPRESSION FRACTURE 96 0.0179
148 RALES 104 0.0179
149 CONTUSION 1719 0.0178
150 VASCULAR DEVICE INFECTION 81 0.0178
151 MACULAR DEGENERATION 213 0.0178
152 MUSCLE SPASMS 3271 0.0178
153 PARANASAL SINUS HYPERSECRETION 68 0.0178
154 LUMBAR VERTEBRAL FRACTURE 81 0.0177
155 ROAD TRAFFIC ACCIDENT 738 0.0176
156 DECREASED INTEREST 104 0.0176
157 SKIN LACERATION 191 0.0175
158 SPINAL OSTEOARTHRITIS 154 0.0175
159 PARAESTHESIA ORAL 252 0.0175
160 TRIGGER FINGER 71 0.0174
161 LIVER DISORDER 767 0.0173
162 LYMPHOEDEMA 119 0.0172
163 BODY HEIGHT DECREASED 184 0.0172
164 JOINT STIFFNESS 450 0.0171
165 MUSCULOSKELETAL STIFFNESS 1481 0.0169
166 RASH VESICULAR 80 0.0165
167 LIVER FUNCTION TEST INCREASED 355 0.0165
168 TRIGEMINAL NEURALGIA 66 0.0164
169 GLUCOSE TOLERANCE IMPAIRED 97 0.0164
170 ORAL CANDIDIASIS 215 0.0163
171 INCREASED TENDENCY TO BRUISE 150 0.0163
172 C-REACTIVE PROTEIN INCREASED 591 0.0162
173 BLOOD CALCIUM DECREASED 182 0.0162
174 JOINT SWELLING 1932 0.0160
175 BLOOD POTASSIUM DECREASED 481 0.0160
176 APPETITE DISORDER 106 0.0160
177 PREGNANCY 316 0.0158
178 PERIPHERAL SWELLING 2423 0.0157
179 INTERVERTEBRAL DISC DEGENERATION 145 0.0157
180 UPPER-AIRWAY COUGH SYNDROME 129 0.0156
181 THERAPY NON-RESPONDER 703 0.0156
182 HEPATIC ENZYME ABNORMAL 78 0.0156
183 TENDONITIS 242 0.0156
184 TENSION HEADACHE 67 0.0156
185 SWELLING 1456 0.0155
186 FAECES SOFT 113 0.0155
187 PHOTOPHOBIA 292 0.0155
188 VAGINAL DISCHARGE 157 0.0155
189 INCORRECT DRUG ADMINISTRATION RATE 66 0.0155
190 DIZZINESS POSTURAL 150 0.0155
191 EXERCISE TOLERANCE DECREASED 89 0.0154
192 TORSADE DE POINTES 121 0.0154
193 BOWEL MOVEMENT IRREGULARITY 118 0.0154
194 VITAMIN D DEFICIENCY 150 0.0154
195 HYPERVOLAEMIA 76 0.0154
196 INJURY 1080 0.0153
197 GINGIVAL PAIN 122 0.0153
198 TONGUE DISCOMFORT 65 0.0153
199 NEURALGIA 372 0.0153
200 BLOOD CALCIUM INCREASED 134 0.0153
201 NERVE COMPRESSION 141 0.0153
202 NECK PAIN 853 0.0152
203 BODY TEMPERATURE DECREASED 150 0.0152
204 HYPOAESTHESIA 2266 0.0151
205 MUSCULAR WEAKNESS 1717 0.0151
206 DYSPEPSIA 1480 0.0150
207 RESTLESS LEGS SYNDROME 273 0.0150
208 MATERNAL EXPOSURE DURING PREGNANCY 1335 0.0150
209 ONYCHOCLASIS 103 0.0150
210 POOR QUALITY SLEEP 322 0.0149
211 VITAMIN D DECREASED 127 0.0148
212 CARDIAC FLUTTER 96 0.0148
213 GASTROOESOPHAGEAL REFLUX DISEASE 1193 0.0148
214 EYE PAIN 836 0.0148
215 MUSCLE STRAIN 128 0.0148
216 OSTEOPOROSIS 607 0.0147
217 GASTROINTESTINAL DISORDER 1315 0.0147
218 ANAL INCONTINENCE 132 0.0147
219 DRY THROAT 149 0.0146
220 SINUS DISORDER 290 0.0146
221 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 703 0.0146
222 EYE INFECTION 165 0.0146
223 HAEMOGLOBIN INCREASED 66 0.0145
224 NEPHROGENIC ANAEMIA 67 0.0144
225 INFUSION SITE EXTRAVASATION 90 0.0144
226 INFLAMMATION 745 0.0144
227 OCULAR DISCOMFORT 161 0.0143
228 TRANSFUSION 150 0.0143
229 DRUG INTOLERANCE 1381 0.0143
230 DERMATITIS CONTACT 163 0.0143
231 INSURANCE ISSUE 217 0.0142
232 DELIRIUM 491 0.0141
233 DEFAECATION URGENCY 99 0.0141
234 GROIN PAIN 124 0.0141
235 SKIN ATROPHY 81 0.0141
236 EPILEPSY 430 0.0141
237 BLOOD PRESSURE FLUCTUATION 337 0.0140
238 MUSCLE TIGHTNESS 227 0.0140
239 LABORATORY TEST ABNORMAL 413 0.0140
240 RED BLOOD CELL COUNT DECREASED 399 0.0139
241 PARAESTHESIA 2193 0.0139
242 DECREASED ACTIVITY 150 0.0139
243 HEAD DISCOMFORT 245 0.0138
244 MEMORY IMPAIRMENT 1898 0.0138
245 HYPERLIPIDAEMIA 165 0.0138
246 OVERWEIGHT 74 0.0138
247 IMPAIRED WORK ABILITY 292 0.0136
248 HYPOCALCAEMIA 258 0.0136
249 PAIN IN JAW 386 0.0136
250 FULL BLOOD COUNT ABNORMAL 144 0.0136
251 TOOTH INFECTION 179 0.0136
252 RESPIRATORY DISORDER 406 0.0136
253 GENERAL PHYSICAL HEALTH DETERIORATION 1570 0.0136
254 BLOOD PRESSURE SYSTOLIC INCREASED 263 0.0135
255 LIGAMENT SPRAIN 133 0.0134
256 RHEUMATOID ARTHRITIS 1525 0.0134
257 ABDOMINAL DISCOMFORT 2245 0.0134
258 NASOPHARYNGITIS 2461 0.0133
259 GAIT DISTURBANCE 2555 0.0133
260 DYSPNOEA EXERTIONAL 500 0.0133
261 NOCTURIA 161 0.0132
262 BLOOD ALBUMIN DECREASED 105 0.0132
263 LIMB INJURY 359 0.0132
264 CANDIDA INFECTION 223 0.0132
265 ELECTROLYTE IMBALANCE 152 0.0131
266 PRODUCTIVE COUGH 623 0.0130
267 MICTURITION URGENCY 149 0.0130
268 PERONEAL NERVE PALSY 74 0.0130
269 IMMUNODEFICIENCY 194 0.0130
270 VENTRICULAR EXTRASYSTOLES 135 0.0130
271 INTENTIONAL PRODUCT USE ISSUE 1138 0.0130
272 PELVIC FRACTURE 101 0.0130
273 ABDOMINAL PAIN UPPER 2670 0.0130
274 FULL BLOOD COUNT DECREASED 261 0.0129
275 CYSTITIS 412 0.0129
276 HEART RATE ABNORMAL 72 0.0129
277 JOINT EFFUSION 89 0.0129
278 SLEEP APNOEA SYNDROME 246 0.0129
279 PURPURA 114 0.0129
280 POOR VENOUS ACCESS 133 0.0128
281 BALANCE DISORDER 1108 0.0128
282 AMNESIA 833 0.0128
283 RECTAL HAEMORRHAGE 550 0.0128
284 PARTIAL SEIZURES 67 0.0128
285 TEMPERATURE INTOLERANCE 132 0.0128
286 HEART RATE IRREGULAR 289 0.0128
287 ATRIAL FLUTTER 102 0.0128
288 ILL-DEFINED DISORDER 773 0.0127
289 RENAL CYST 101 0.0127
290 HYPERKERATOSIS 70 0.0127
291 ARTHROPOD BITE 94 0.0127
292 NEUROPATHY PERIPHERAL 1205 0.0127
293 ORAL HERPES 247 0.0126
294 ORAL PAIN 283 0.0126
295 WEIGHT INCREASED 2830 0.0126
296 MUSCLE ATROPHY 160 0.0126
297 SINUS HEADACHE 75 0.0126
298 IMPAIRED QUALITY OF LIFE 181 0.0126
299 HEART RATE DECREASED 442 0.0126
300 MIDDLE INSOMNIA 234 0.0125
301 CONSTIPATION 2725 0.0125
302 SQUAMOUS CELL CARCINOMA OF SKIN 75 0.0124
303 DIVERTICULITIS 343 0.0124
304 TINNITUS 564 0.0123
305 TOOTH ABSCESS 125 0.0123
306 INSOMNIA 3261 0.0122
307 FACIAL PAIN 109 0.0122
308 DECREASED APPETITE 2835 0.0122
309 DENTAL CARIES 135 0.0122
310 ARTHRITIS 959 0.0122
311 OSTEOPENIA 185 0.0122
312 INITIAL INSOMNIA 125 0.0122
313 EXTRASYSTOLES 85 0.0122
314 FLATULENCE 690 0.0122
315 CARPAL TUNNEL SYNDROME 170 0.0121
316 SWELLING OF EYELID 76 0.0121
317 MUSCLE TWITCHING 279 0.0121
318 PRODUCT ADMINISTRATION INTERRUPTED 95 0.0121
319 BRONCHITIS 895 0.0121
320 FLUID RETENTION 615 0.0121
321 DYSSTASIA 353 0.0121
322 FEELING COLD 336 0.0121
323 HYPERAESTHESIA 99 0.0120
324 MUSCULOSKELETAL DISCOMFORT 207 0.0120
325 UPPER RESPIRATORY TRACT INFECTION 555 0.0120
326 ASTHENIA 4515 0.0120
327 APHTHOUS ULCER 93 0.0120
328 LARGE INTESTINE POLYP 83 0.0120
329 SECRETION DISCHARGE 150 0.0120
330 GASTROINTESTINAL MOTILITY DISORDER 64 0.0119
331 ALOPECIA 2343 0.0119
332 LIMB DISCOMFORT 369 0.0119
333 FOOD ALLERGY 92 0.0119
334 WHITE BLOOD CELL COUNT ABNORMAL 76 0.0119
335 RESPIRATORY TRACT INFECTION 309 0.0119
336 SPINAL COMPRESSION FRACTURE 98 0.0118
337 GASTROENTERITIS VIRAL 214 0.0118
338 FATIGUE 9211 0.0118
339 GASTROINTESTINAL INFECTION 106 0.0118
340 ARTHRALGIA 4916 0.0118
341 PAIN IN EXTREMITY 3475 0.0118
342 OXYGEN SATURATION DECREASED 662 0.0118
343 RESPIRATORY TRACT CONGESTION 187 0.0118
344 ROTATOR CUFF SYNDROME 151 0.0117
345 PREMATURE DELIVERY 187 0.0117
346 ABDOMINAL DISTENSION 1224 0.0117
347 RIB FRACTURE 241 0.0117
348 BONE PAIN 686 0.0117
349 EAR DISCOMFORT 120 0.0117
350 ENERGY INCREASED 69 0.0117
351 HEART RATE INCREASED 1156 0.0117
352 NASAL DRYNESS 73 0.0116
353 URINARY TRACT INFECTION 1985 0.0116
354 SINUS CONGESTION 157 0.0116
355 THYROID DISORDER 179 0.0116
356 COVID-19 PNEUMONIA 137 0.0116
357 CONFUSIONAL STATE 1875 0.0116
358 INTERVERTEBRAL DISC PROTRUSION 253 0.0116
359 MUSCULOSKELETAL CHEST PAIN 179 0.0116
360 CHEST PAIN 2142 0.0116
361 WHITE BLOOD CELL COUNT INCREASED 442 0.0115
362 TENDERNESS 120 0.0115
363 TOOTH DISORDER 256 0.0115
364 PRODUCT LABEL CONFUSION 67 0.0115
365 GASTROINTESTINAL PAIN 126 0.0114
366 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 196 0.0114
367 PRODUCT DISTRIBUTION ISSUE 106 0.0114
368 DRY EYE 569 0.0114
369 BACK DISORDER 185 0.0114
370 KIDNEY INFECTION 223 0.0114
371 WEIGHT DECREASED 3171 0.0113
372 ASTHMA 1283 0.0113
373 HYPERSOMNIA 324 0.0113
374 SMALL INTESTINAL OBSTRUCTION 139 0.0113
375 BLOOD COUNT ABNORMAL 171 0.0113
376 FEELING HOT 691 0.0113
377 TOOTHACHE 204 0.0113
378 HYPERCALCAEMIA 139 0.0112
379 SKIN MASS 75 0.0112
380 HOT FLUSH 846 0.0112
381 OEDEMA PERIPHERAL 1368 0.0112
382 BASAL CELL CARCINOMA 175 0.0112
383 BLOOD PRESSURE ABNORMAL 221 0.0111
384 ABNORMAL FAECES 91 0.0111
385 BLOOD TEST ABNORMAL 156 0.0111
386 FEELING OF BODY TEMPERATURE CHANGE 65 0.0111
387 HYPERTRANSAMINASAEMIA 77 0.0111
388 HEPATIC STEATOSIS 206 0.0110
389 PRE-EXISTING CONDITION IMPROVED 69 0.0110
390 HIATUS HERNIA 143 0.0110
391 BLOOD SODIUM DECREASED 208 0.0110
392 QUALITY OF LIFE DECREASED 148 0.0110
393 FOREIGN BODY SENSATION IN EYES 70 0.0110
394 TOOTH FRACTURE 121 0.0110
395 INFECTION 1586 0.0109
396 ATRIAL FIBRILLATION 1067 0.0109
397 HYPERTENSION 2311 0.0109
398 SENSORY DISTURBANCE 175 0.0109
399 BLOOD PRESSURE INCREASED 1664 0.0109
400 DIARRHOEA 7024 0.0109
401 BACK PAIN 2526 0.0109
402 IMPAIRED GASTRIC EMPTYING 148 0.0108
403 JOINT INJURY 231 0.0108
404 NERVE INJURY 120 0.0108
405 BODY TEMPERATURE INCREASED 220 0.0108
406 CATARACT 641 0.0108
407 APHONIA 150 0.0107
408 HYPOKINESIA 156 0.0107
409 PALPITATIONS 1258 0.0107
410 PHARYNGEAL SWELLING 105 0.0107
411 ODYNOPHAGIA 64 0.0107
412 CONCUSSION 83 0.0107
413 VITREOUS FLOATERS 105 0.0107
414 SPUTUM DISCOLOURED 101 0.0106
415 TROPONIN INCREASED 81 0.0106
416 NEUTROPENIC SEPSIS 76 0.0106
417 DIZZINESS 5306 0.0106
418 THIRST 190 0.0106
419 MYALGIA 1807 0.0106
420 SPINAL PAIN 124 0.0106
421 PROCTALGIA 68 0.0106
422 IMMUNOSUPPRESSION 93 0.0105
423 VENTRICULAR TACHYCARDIA 174 0.0105
424 BEDRIDDEN 138 0.0105
425 PANIC ATTACK 382 0.0105
426 BLADDER DISORDER 104 0.0105
427 DISABILITY 207 0.0105
428 HERNIA 202 0.0104
429 BLOOD URINE PRESENT 198 0.0104
430 TREATMENT FAILURE 859 0.0104
431 VIRAL INFECTION 345 0.0104
432 FEEDING DISORDER 210 0.0103
433 HEREDITARY ANGIOEDEMA 111 0.0103
434 MUSCLE SPASTICITY 127 0.0103
435 HOSPICE CARE 102 0.0103
436 PULMONARY HYPERTENSION 215 0.0103
437 DEPRESSION 2337 0.0103
438 WRIST FRACTURE 123 0.0103
439 LOCALISED INFECTION 248 0.0102
440 PERIPHERAL COLDNESS 140 0.0102
441 DISTURBANCE IN ATTENTION 549 0.0102
442 PHOTOSENSITIVITY REACTION 168 0.0102
443 HEADACHE 6359 0.0101
444 PRODUCT DOSE OMISSION IN ERROR 287 0.0101
445 FOOT FRACTURE 192 0.0101
446 RHINORRHOEA 654 0.0101
447 COUGH 2832 0.0101
448 GLOMERULAR FILTRATION RATE DECREASED 124 0.0101
449 OROPHARYNGEAL PAIN 934 0.0101
450 SENSATION OF FOREIGN BODY 85 0.0101
451 DEHYDRATION 1344 0.0101
452 CELLULITIS 507 0.0101
453 ANXIETY 2862 0.0100
454 DYSPHONIA 588 0.0100
455 TENDON RUPTURE 124 0.0100
456 BLOOD POTASSIUM INCREASED 163 0.0100
457 SPINAL DISORDER 95 0.0100
458 INCONTINENCE 106 0.0100
459 URINARY INCONTINENCE 297 0.0100
460 HAEMORRHOIDS 195 0.0100
461 LACRIMATION INCREASED 302 0.0100
462 CYST 124 0.0100
463 HAEMATOCRIT DECREASED 198 0.0100
464 COLITIS ULCERATIVE 445 0.0099
465 POSTOPERATIVE WOUND INFECTION 67 0.0099
466 EYE DISCHARGE 103 0.0099
467 SQUAMOUS CELL CARCINOMA 93 0.0099
468 FALL 3277 0.0098
469 DECUBITUS ULCER 80 0.0098
470 GOUT 176 0.0098
471 PULMONARY MASS 146 0.0098
472 COVID-19 1718 0.0098
473 EXPOSURE DURING PREGNANCY 608 0.0098
474 IRON DEFICIENCY ANAEMIA 90 0.0097
475 POLLAKIURIA 406 0.0097
476 GRAFT VERSUS HOST DISEASE 70 0.0097
477 POST PROCEDURAL INFECTION 79 0.0097
478 BREAST MASS 65 0.0097
479 PAROSMIA 73 0.0097
480 ARTERIOSCLEROSIS 91 0.0097
481 BREAST PAIN 103 0.0096
482 OROPHARYNGEAL DISCOMFORT 87 0.0096
483 MUSCLE DISORDER 78 0.0096
484 PNEUMONIA 3117 0.0096
485 SARS-COV-2 TEST POSITIVE 127 0.0096
486 SUPRAVENTRICULAR TACHYCARDIA 92 0.0096
487 PLATELET COUNT INCREASED 125 0.0096
488 THROAT IRRITATION 429 0.0096
489 ELECTROCARDIOGRAM ABNORMAL 75 0.0095
490 GENERALISED OEDEMA 118 0.0095
491 NEPHROPATHY 89 0.0095
492 IMPAIRED DRIVING ABILITY 108 0.0095
493 FLANK PAIN 89 0.0095
494 URTICARIA 1589 0.0095
495 SKIN DISORDER 316 0.0095
496 SCAB 108 0.0095
497 BURNING SENSATION 664 0.0095
498 MOVEMENT DISORDER 304 0.0095
499 FUNGAL INFECTION 315 0.0094
500 COGNITIVE DISORDER 441 0.0094
501 WHITE BLOOD CELL COUNT DECREASED 1023 0.0094
502 NASAL CONGESTION 554 0.0094
503 SLUGGISHNESS 96 0.0094
504 URINE OUTPUT DECREASED 82 0.0094
505 RASH PRURITIC 508 0.0094
506 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 666 0.0094
507 BLOOD THYROID STIMULATING HORMONE INCREASED 86 0.0093
508 HYPOPHOSPHATAEMIA 69 0.0093
509 APATHY 136 0.0093
510 SKIN HAEMORRHAGE 138 0.0093
511 CHILLS 1091 0.0093
512 FEELING JITTERY 177 0.0093
513 DYSPNOEA 5252 0.0093
514 NEPHROLITHIASIS 425 0.0093
515 IMMUNE SYSTEM DISORDER 122 0.0092
516 THERAPY CHANGE 91 0.0092
517 PAIN 5682 0.0092
518 HAEMATOCHEZIA 510 0.0092
519 FORMICATION 64 0.0092
520 HAEMOGLOBIN DECREASED 944 0.0092
521 RETCHING 196 0.0092
522 BLOOD PRESSURE DECREASED 610 0.0092
523 CHEST DISCOMFORT 939 0.0092
524 UTERINE LEIOMYOMA 67 0.0092
525 HYPOKALAEMIA 423 0.0092
526 CLOSTRIDIUM DIFFICILE INFECTION 200 0.0092
527 INTENTIONAL DOSE OMISSION 261 0.0091
528 ABDOMINAL PAIN 2129 0.0091
529 ORAL DISORDER 67 0.0091
530 SPLENOMEGALY 107 0.0091
531 BLOOD DISORDER 73 0.0091
532 SKIN FISSURES 178 0.0091
533 SPINAL FRACTURE 182 0.0091
534 NAUSEA 7182 0.0091
535 EPISTAXIS 677 0.0090
536 PLATELET COUNT DECREASED 964 0.0090
537 ANKLE FRACTURE 140 0.0090
538 ILLNESS 931 0.0090
539 HYPOPHAGIA 231 0.0090
540 PRODUCT SUBSTITUTION ISSUE 520 0.0090
541 GALLBLADDER DISORDER 161 0.0090
542 HIP FRACTURE 290 0.0090
543 FEELING ABNORMAL 2160 0.0090
544 EYE INFLAMMATION 86 0.0090
545 RESPIRATORY RATE INCREASED 80 0.0090
546 SNEEZING 202 0.0090
547 LYMPHOCYTE COUNT DECREASED 159 0.0090
548 PROCEDURAL PAIN 249 0.0090
549 TRICUSPID VALVE INCOMPETENCE 71 0.0089
550 GASTROINTESTINAL INFLAMMATION 70 0.0089
551 BACTERAEMIA 106 0.0089
552 GLAUCOMA 172 0.0089
553 MUCOSAL INFLAMMATION 233 0.0089
554 THERAPY CESSATION 456 0.0089
555 PANIC REACTION 64 0.0089
556 HEAD INJURY 280 0.0088
557 RESPIRATORY SYNCYTIAL VIRUS INFECTION 77 0.0088
558 NASAL DISCOMFORT 70 0.0088
559 LOW BIRTH WEIGHT BABY 70 0.0088
560 PULMONARY THROMBOSIS 96 0.0088
561 ATELECTASIS 85 0.0088
562 SKIN INFECTION 98 0.0087
563 ACUTE RESPIRATORY FAILURE 168 0.0087
564 VISUAL IMPAIRMENT 1081 0.0087
565 COLITIS 330 0.0087
566 HYPERSENSITIVITY 1612 0.0087
567 ERUCTATION 168 0.0087
568 CLOSTRIDIUM DIFFICILE COLITIS 92 0.0087
569 SENSITIVE SKIN 64 0.0087
570 GINGIVAL BLEEDING 118 0.0086
571 THINKING ABNORMAL 161 0.0086
572 PREMATURE BABY 260 0.0086
573 RENAL DISORDER 402 0.0086
574 SCRATCH 91 0.0086
575 GASTRITIS 227 0.0086
576 VERTIGO 524 0.0086
577 CONDITION AGGRAVATED 2610 0.0086
578 BACTERIAL INFECTION 160 0.0086
579 DYSKINESIA 348 0.0086
580 HYPOTHYROIDISM 272 0.0085
581 RENAL PAIN 90 0.0085
582 VISION BLURRED 1165 0.0085
583 ADVERSE DRUG REACTION 761 0.0085
584 HUNGER 118 0.0085
585 PRURITUS 3253 0.0085
586 VOMITING 3971 0.0084
587 NODULE 110 0.0084
588 CHOLELITHIASIS 276 0.0084
589 INFLUENZA 938 0.0084
590 INTESTINAL OBSTRUCTION 317 0.0084
591 ADRENAL INSUFFICIENCY 102 0.0084
592 MITRAL VALVE INCOMPETENCE 95 0.0084
593 SCAR 143 0.0083
594 FAECES DISCOLOURED 181 0.0083
595 TREMOR 1385 0.0083
596 PRESYNCOPE 202 0.0083
597 FRUSTRATION TOLERANCE DECREASED 67 0.0083
598 EYE IRRITATION 477 0.0083
599 POST PROCEDURAL COMPLICATION 159 0.0083
600 LYMPHADENOPATHY 293 0.0083
601 FEBRILE NEUTROPENIA 549 0.0083
602 HERPES ZOSTER 475 0.0083
603 HALLUCINATION 623 0.0083
604 HYPOAESTHESIA ORAL 124 0.0082
605 HALLUCINATION, VISUAL 173 0.0082
606 PRODUCT USE COMPLAINT 129 0.0082
607 FEAR 220 0.0082
608 PYREXIA 2830 0.0082
609 PNEUMONIA BACTERIAL 75 0.0082
610 BONE DISORDER 148 0.0081
611 MOUTH ULCERATION 171 0.0081
612 MUSCULOSKELETAL DISORDER 154 0.0081
613 MASS 113 0.0081
614 SKIN CANCER 174 0.0081
615 BLOOD UREA INCREASED 135 0.0081
616 AGEUSIA 201 0.0080
617 FLUSHING 819 0.0080
618 MALAISE 3532 0.0080
619 LETHARGY 463 0.0080
620 ANAEMIA 1534 0.0080
621 RESTLESSNESS 294 0.0080
622 UPPER LIMB FRACTURE 160 0.0080
623 SKIN DISCOLOURATION 369 0.0080
624 CORONARY ARTERY OCCLUSION 110 0.0080
625 PANCREATITIS 423 0.0080
626 ORAL DISCOMFORT 111 0.0080
627 DIPLOPIA 207 0.0080
628 PERSONALITY CHANGE 74 0.0080
629 MALNUTRITION 89 0.0079
630 HEPATOMEGALY 78 0.0079
631 ARRHYTHMIA 375 0.0079
632 EYE DISORDER 260 0.0079
633 END STAGE RENAL DISEASE 144 0.0079
634 PLASMA CELL MYELOMA 307 0.0079
635 COELIAC DISEASE 77 0.0078
636 EATING DISORDER 167 0.0078
637 BLOOD CREATININE INCREASED 512 0.0078
638 ELECTROCARDIOGRAM QT PROLONGED 282 0.0078
639 DYSPHAGIA 743 0.0078
640 RASH 3404 0.0078
641 MYOSITIS 70 0.0078
642 EJECTION FRACTION DECREASED 121 0.0078
643 APHASIA 235 0.0078
644 SPEECH DISORDER 406 0.0077
645 BIPOLAR DISORDER 84 0.0077
646 DYSGEUSIA 573 0.0077
647 PRODUCT USE ISSUE 1448 0.0077
648 HAIR TEXTURE ABNORMAL 103 0.0077
649 MUSCLE RIGIDITY 92 0.0077
650 INFLUENZA LIKE ILLNESS 633 0.0077
651 NIGHTMARE 266 0.0077
652 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 401 0.0077
653 CRYING 279 0.0077
654 TRANSIENT ISCHAEMIC ATTACK 259 0.0077
655 THROMBOSIS 617 0.0077
656 PRODUCT ADMINISTRATION ERROR 155 0.0077
657 ULCER 122 0.0077
658 CHRONIC KIDNEY DISEASE 581 0.0076
659 ORTHOSTATIC HYPOTENSION 133 0.0076
660 HAIR COLOUR CHANGES 95 0.0076
661 DEPRESSED MOOD 402 0.0076
662 MENTAL IMPAIRMENT 184 0.0076
663 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 67 0.0076
664 NERVOUSNESS 395 0.0076
665 DYSURIA 277 0.0075
666 PRODUCT DOSE OMISSION ISSUE 2211 0.0075
667 POLYNEUROPATHY 90 0.0075
668 PHARYNGITIS 93 0.0075
669 CONJUNCTIVITIS 139 0.0075
670 CARDIOMEGALY 92 0.0075
671 EYE PRURITUS 251 0.0075
672 HYPOTENSION 1496 0.0075
673 HYPERHIDROSIS 958 0.0074
674 EMPHYSEMA 75 0.0074
675 SKIN ULCER 192 0.0074
676 STAPHYLOCOCCAL INFECTION 245 0.0074
677 PRODUCT USE IN UNAPPROVED INDICATION 1838 0.0074
678 DELUSION 115 0.0074
679 PHARYNGITIS STREPTOCOCCAL 80 0.0074
680 HYPOXIA 260 0.0074
681 VENTRICULAR FIBRILLATION 82 0.0074
682 CHROMATURIA 166 0.0073
683 EYE HAEMORRHAGE 98 0.0073
684 CIRCULATORY COLLAPSE 125 0.0073
685 THERAPY INTERRUPTED 523 0.0073
686 APPENDICITIS 68 0.0073
687 UROSEPSIS 67 0.0073
688 INABILITY TO AFFORD MEDICATION 72 0.0072
689 DECREASED IMMUNE RESPONSIVENESS 71 0.0072
690 DEVICE OCCLUSION 101 0.0072
691 THERAPEUTIC RESPONSE UNEXPECTED 321 0.0071
692 OESOPHAGITIS 78 0.0071
693 SYNCOPE 714 0.0071
694 OCULAR HYPERAEMIA 338 0.0071
695 ACTIVITIES OF DAILY LIVING IMPAIRED 141 0.0071
696 COLD SWEAT 125 0.0071
697 EYE SWELLING 263 0.0071
698 GASTROENTERITIS 103 0.0071
699 SKIN LESION 193 0.0070
700 CHOKING 137 0.0070
701 PERICARDIAL EFFUSION 162 0.0070
702 PULMONARY OEDEMA 313 0.0070
703 MULTIPLE SCLEROSIS 333 0.0070
704 THERAPEUTIC RESPONSE SHORTENED 230 0.0069
705 CYTOKINE RELEASE SYNDROME 139 0.0069
706 INTERNAL HAEMORRHAGE 79 0.0069
707 HAEMATOMA 179 0.0069
708 PROSTATIC SPECIFIC ANTIGEN INCREASED 95 0.0069
709 PRODUCT PRESCRIBING ERROR 164 0.0069
710 ABDOMINAL PAIN LOWER 174 0.0069
711 NEUTROPHIL COUNT INCREASED 70 0.0068
712 SINUS BRADYCARDIA 66 0.0068
713 HAEMOPTYSIS 190 0.0068
714 LACERATION 64 0.0068
715 OSTEOMYELITIS 123 0.0068
716 MOOD SWINGS 216 0.0068
717 DISORIENTATION 268 0.0068
718 THERAPEUTIC RESPONSE DECREASED 410 0.0068
719 SOMNOLENCE 1360 0.0067
720 TACHYCARDIA 598 0.0067
721 NEUTROPHIL COUNT DECREASED 273 0.0067
722 TACHYPNOEA 91 0.0067
723 DRUG EFFECT LESS THAN EXPECTED 99 0.0067
724 COORDINATION ABNORMAL 93 0.0067
725 INCREASED APPETITE 127 0.0066
726 RASH MACULAR 232 0.0066
727 PULMONARY ARTERIAL HYPERTENSION 96 0.0066
728 WITHDRAWAL SYNDROME 278 0.0066
729 DRY SKIN 883 0.0066
730 BLOOD ALKALINE PHOSPHATASE INCREASED 164 0.0066
731 OBSTRUCTIVE AIRWAYS DISORDER 73 0.0066
732 PLEURAL EFFUSION 399 0.0066
733 RENAL IMPAIRMENT 549 0.0065
734 MOTOR DYSFUNCTION 66 0.0065
735 SEPSIS 720 0.0064
736 PRODUCT AVAILABILITY ISSUE 146 0.0064
737 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1151 0.0064
738 DEVICE RELATED INFECTION 98 0.0064
739 MENTAL STATUS CHANGES 176 0.0063
740 ADVERSE EVENT 584 0.0063
741 PETECHIAE 66 0.0063
742 NERVOUS SYSTEM DISORDER 197 0.0063
743 LIP SWELLING 210 0.0063
744 PNEUMOTHORAX 100 0.0063
745 LOSS OF CONSCIOUSNESS 804 0.0063
746 SKIN EXFOLIATION 525 0.0062
747 IRRITABILITY 374 0.0062
748 HYPERTHYROIDISM 90 0.0062
749 UNEVALUABLE EVENT 470 0.0062
750 ANGER 210 0.0062
751 PRODUCT ODOUR ABNORMAL 65 0.0062
752 ABNORMAL DREAMS 171 0.0062
753 ECZEMA 324 0.0062
754 SWELLING FACE 403 0.0062
755 DYSMENORRHOEA 82 0.0062
756 HYPONATRAEMIA 348 0.0062
757 DERMATITIS 129 0.0062
758 OFF LABEL USE 5385 0.0061
759 MOOD ALTERED 167 0.0061
760 RENAL FAILURE 813 0.0061
761 NEOPLASM PROGRESSION 212 0.0061
762 CARDIAC DISORDER 567 0.0061
763 INJECTION SITE BRUISING 483 0.0060
764 MELAENA 133 0.0060
765 BONE DENSITY DECREASED 189 0.0060
766 SUICIDAL IDEATION 552 0.0060
767 ASPIRATION 66 0.0060
768 MULTIPLE SCLEROSIS RELAPSE 413 0.0060
769 INJECTION SITE DISCOLOURATION 75 0.0060
770 CHOLECYSTECTOMY 68 0.0059
771 THROAT TIGHTNESS 161 0.0059
772 CARDIAC FAILURE CONGESTIVE 478 0.0059
773 TOOTH EXTRACTION 74 0.0059
774 GASTRIC ULCER 113 0.0059
775 ANGINA PECTORIS 170 0.0059
776 PULMONARY CONGESTION 78 0.0059
777 METASTASES TO BONE 97 0.0059
778 GASTRIC DISORDER 201 0.0059
779 DYSARTHRIA 220 0.0058
780 BLOOD TRIGLYCERIDES INCREASED 103 0.0058
781 DEAFNESS 152 0.0058
782 HYPOACUSIS 250 0.0058
783 METASTASES TO LIVER 102 0.0058
784 ACUTE KIDNEY INJURY 887 0.0058
785 LUNG INFECTION 90 0.0058
786 GAMMA-GLUTAMYLTRANSFERASE INCREASED 128 0.0058
787 FLUID OVERLOAD 84 0.0058
788 PNEUMONITIS 157 0.0058
789 EMOTIONAL DISORDER 177 0.0057
790 PRODUCT QUALITY ISSUE 778 0.0057
791 RASH ERYTHEMATOUS 272 0.0057
792 ERYTHEMA 1169 0.0057
793 MADAROSIS 66 0.0057
794 SKIN REACTION 80 0.0057
795 CENTRAL NERVOUS SYSTEM LESION 78 0.0057
796 PELVIC PAIN 103 0.0057
797 STATUS EPILEPTICUS 64 0.0057
798 GLYCOSYLATED HAEMOGLOBIN INCREASED 143 0.0057
799 VASCULITIS 66 0.0057
800 MENTAL DISORDER 246 0.0056
801 DRUG-INDUCED LIVER INJURY 177 0.0056
802 BLOOD CREATINE PHOSPHOKINASE INCREASED 162 0.0056
803 PRODUCT PHYSICAL ISSUE 113 0.0056
804 THROMBOCYTOPENIA 625 0.0056
805 ASCITES 164 0.0056
806 ABSCESS 89 0.0056
807 PANCYTOPENIA 311 0.0056
808 GENERALISED TONIC-CLONIC SEIZURE 92 0.0056
809 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 305 0.0056
810 FEMUR FRACTURE 172 0.0055
811 URINARY RETENTION 185 0.0055
812 SWOLLEN TONGUE 173 0.0055
813 UPPER GASTROINTESTINAL HAEMORRHAGE 93 0.0055
814 SEIZURE 636 0.0055
815 PRODUCT TASTE ABNORMAL 74 0.0055
816 MEDICATION ERROR 303 0.0054
817 BLOOD BILIRUBIN INCREASED 147 0.0054
818 HEMIPARESIS 92 0.0054
819 INTERNATIONAL NORMALISED RATIO INCREASED 154 0.0054
820 RASH PAPULAR 121 0.0054
821 UNDERDOSE 394 0.0054
822 PARANOIA 93 0.0054
823 PAIN OF SKIN 145 0.0054
824 PRODUCT DOSE OMISSION 351 0.0054
825 MALIGNANT MELANOMA 72 0.0054
826 COMPLICATION ASSOCIATED WITH DEVICE 78 0.0054
827 CARDIOMYOPATHY 79 0.0053
828 MULTIPLE ORGAN DYSFUNCTION SYNDROME 151 0.0053
829 SINUS TACHYCARDIA 75 0.0053
830 LEUKOPENIA 262 0.0052
831 MULTIPLE FRACTURES 86 0.0052
832 CARDIAC FAILURE 420 0.0052
833 HAEMATEMESIS 132 0.0052
834 NEEDLE ISSUE 151 0.0052
835 BRONCHOSPASM 74 0.0052
836 DRUG INTERACTION 818 0.0052
837 ECONOMIC PROBLEM 78 0.0051
838 HYPERKALAEMIA 179 0.0051
839 SURGERY 299 0.0051
840 DISEASE RECURRENCE 240 0.0050
841 PULMONARY EMBOLISM 477 0.0050
842 TREATMENT NONCOMPLIANCE 274 0.0050
843 LYMPHOPENIA 70 0.0049
844 BRADYCARDIA 262 0.0049
845 HAEMATURIA 169 0.0049
846 INTENTIONAL PRODUCT MISUSE 432 0.0049
847 CYANOSIS 77 0.0049
848 BLOOD GLUCOSE DECREASED 235 0.0049
849 GASTROINTESTINAL HAEMORRHAGE 408 0.0049
850 BLOOD LACTATE DEHYDROGENASE INCREASED 77 0.0049
851 INCORRECT PRODUCT ADMINISTRATION DURATION 105 0.0048
852 SEROTONIN SYNDROME 93 0.0048
853 INJECTION SITE MASS 179 0.0048
854 AGITATION 355 0.0048
855 INJECTION SITE RASH 148 0.0048
856 ALANINE AMINOTRANSFERASE INCREASED 296 0.0048
857 ACUTE MYELOID LEUKAEMIA 75 0.0048
858 HAEMORRHAGE 502 0.0048
859 DIABETES MELLITUS 365 0.0048
860 RESPIRATORY DISTRESS 132 0.0048
861 HEPATITIS 122 0.0048
862 PRURITUS GENERALISED 103 0.0048
863 ASPARTATE AMINOTRANSFERASE INCREASED 252 0.0047
864 INJECTION SITE REACTION 326 0.0047
865 PROTEINURIA 89 0.0047
866 PARALYSIS 67 0.0047
867 PALLOR 127 0.0047
868 PSORIASIS 609 0.0047
869 BLOOD GLUCOSE ABNORMAL 86 0.0047
870 INJECTION SITE PRURITUS 311 0.0046
871 LEUKOCYTOSIS 84 0.0046
872 HOSPITALISATION 708 0.0046
873 RESPIRATORY FAILURE 336 0.0046
874 FRACTURE 87 0.0046
875 RENAL INJURY 136 0.0046
876 DEEP VEIN THROMBOSIS 296 0.0046
877 LOCAL SWELLING 79 0.0045
878 DRUG INEFFECTIVE 5956 0.0045
879 PSYCHOMOTOR HYPERACTIVITY 75 0.0045
880 FOETAL EXPOSURE DURING PREGNANCY 367 0.0045
881 LIVER FUNCTION TEST ABNORMAL 130 0.0045
882 CORONARY ARTERY DISEASE 135 0.0045
883 ANAPHYLACTIC REACTION 246 0.0044
884 MANIA 73 0.0044
885 BLOOD GLUCOSE INCREASED 835 0.0044
886 UNRESPONSIVE TO STIMULI 114 0.0044
887 INJECTION SITE URTICARIA 108 0.0044
888 DEMENTIA 123 0.0044
889 ENCEPHALOPATHY 108 0.0044
890 INJECTION SITE PAIN 1343 0.0044
891 ANHEDONIA 115 0.0044
892 DRUG LEVEL INCREASED 72 0.0043
893 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 101 0.0043
894 DEVICE ISSUE 385 0.0043
895 HYPOGLYCAEMIA 208 0.0043
896 ACUTE MYOCARDIAL INFARCTION 126 0.0043
897 MALIGNANT NEOPLASM PROGRESSION 432 0.0042
898 TOOTH LOSS 87 0.0042
899 DERMATITIS ATOPIC 221 0.0042
900 DIABETES MELLITUS INADEQUATE CONTROL 74 0.0042
901 ABASIA 103 0.0042
902 INJECTION SITE ERYTHEMA 513 0.0041
903 NEUTROPENIA 553 0.0041
904 METABOLIC ACIDOSIS 129 0.0040
905 CARDIAC ARREST 333 0.0040
906 INJECTION SITE HAEMORRHAGE 322 0.0040
907 COAGULOPATHY 67 0.0040
908 EXPIRED PRODUCT ADMINISTERED 133 0.0040
909 HYPERGLYCAEMIA 143 0.0039
910 DEPRESSED LEVEL OF CONSCIOUSNESS 154 0.0039
911 INJECTION SITE SWELLING 298 0.0039
912 DEVICE USE ISSUE 68 0.0039
913 SEPTIC SHOCK 169 0.0039
914 DRUG EFFECT INCOMPLETE 141 0.0039
915 VAGINAL HAEMORRHAGE 168 0.0039
916 SHOCK 89 0.0039
917 INCORRECT DOSE ADMINISTERED 880 0.0039
918 DISEASE PROGRESSION 456 0.0038
919 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 273 0.0038
920 CEREBROVASCULAR ACCIDENT 638 0.0038
921 PNEUMONIA ASPIRATION 94 0.0038
922 EXTRA DOSE ADMINISTERED 152 0.0037
923 PANCREATITIS ACUTE 84 0.0037
924 ABNORMAL BEHAVIOUR 148 0.0037
925 DEVICE DISLOCATION 162 0.0037
926 ACUTE RESPIRATORY DISTRESS SYNDROME 65 0.0037
927 DRUG DOSE OMISSION 602 0.0036
928 APPLICATION SITE PRURITUS 80 0.0035
929 EXPOSURE VIA SKIN CONTACT 91 0.0035
930 APPLICATION SITE PAIN 77 0.0035
931 TRANSAMINASES INCREASED 76 0.0034
932 PRODUCT PRESCRIBING ISSUE 74 0.0034
933 BONE MARROW FAILURE 69 0.0034
934 DEVICE LEAKAGE 146 0.0034
935 PSYCHOTIC DISORDER 99 0.0033
936 DRUG RESISTANCE 86 0.0033
937 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 675 0.0033
938 DRUG PRESCRIBING ERROR 64 0.0033
939 ERECTILE DYSFUNCTION 85 0.0033
940 VISUAL ACUITY REDUCED 108 0.0032
941 APPLICATION SITE ERYTHEMA 85 0.0032
942 BLINDNESS 132 0.0032
943 DEVICE MALFUNCTION 227 0.0032
944 DRUG EFFECT DECREASED 174 0.0032
945 CEREBRAL HAEMORRHAGE 115 0.0032
946 JAUNDICE 85 0.0032
947 OSTEONECROSIS OF JAW 78 0.0031
948 HEPATIC FAILURE 95 0.0031
949 RENAL FAILURE ACUTE 132 0.0031
950 ACNE 235 0.0031
951 ANAPHYLACTIC SHOCK 78 0.0030
952 MYOCARDIAL INFARCTION 526 0.0030
953 SKIN IRRITATION 138 0.0030
954 NEOPLASM MALIGNANT 200 0.0030
955 LACTIC ACIDOSIS 96 0.0030
956 RASH GENERALISED 76 0.0029
957 ACCIDENTAL OVERDOSE 107 0.0029
958 CARDIOVASCULAR DISORDER 74 0.0029
959 AGGRESSION 144 0.0029
960 SKIN BURNING SENSATION 204 0.0028
961 DEATH 2431 0.0028
962 INCORRECT DRUG ADMINISTRATION DURATION 79 0.0028
963 LUNG NEOPLASM MALIGNANT 113 0.0027
964 SEDATION 69 0.0026
965 WRONG TECHNIQUE IN DRUG USAGE PROCESS 94 0.0026
966 DRUG ADMINISTRATION ERROR 77 0.0025
967 ANGIOEDEMA 102 0.0023
968 RHABDOMYOLYSIS 96 0.0023
969 TOXICITY TO VARIOUS AGENTS 387 0.0023
970 INTERSTITIAL LUNG DISEASE 111 0.0023
971 OSTEONECROSIS 74 0.0023
972 DEVICE USE ERROR 77 0.0022
973 BREAST CANCER 206 0.0022
974 ABORTION SPONTANEOUS 88 0.0022
975 EMOTIONAL DISTRESS 261 0.0022
976 PRODUCT ADHESION ISSUE 76 0.0021
977 COMA 100 0.0021
978 CARDIO-RESPIRATORY ARREST 87 0.0021
979 ACCIDENTAL EXPOSURE TO PRODUCT 206 0.0020
980 DRUG WITHDRAWAL SYNDROME 167 0.0019
981 SUICIDE ATTEMPT 114 0.0019
982 INTENTIONAL OVERDOSE 116 0.0018
983 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 84 0.0018
984 DEVICE BREAKAGE 73 0.0018
985 PRODUCT STORAGE ERROR 155 0.0018
986 CONVULSION 98 0.0017
987 OVERDOSE 359 0.0017
988 NO ADVERSE EVENT 279 0.0015
989 DEVICE DIFFICULT TO USE 92 0.0014
990 DRUG DOSE OMISSION BY DEVICE 75 0.0010
991 PROSTATE CANCER 77 0.0010
992 DRUG DEPENDENCE 107 0.0007